Efficacy of short-duration Furazolidone in two different quadruple regimens for H. pylori eradication

Pakistan Journal of Medical Sciences

Volumn 27, Issue 4, 2011, Pages 887-891

  Fakheri, Hafez Tirgar ^a   Fakhri, Moloud ^b   Shahmohammadi, Soheila ^b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Furazolidone; H. pylori eradication; Quadruple regimen

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; FURAZOLIDONE; METRONIDAZOLE; OMEPRAZOLE;

ABDOMINAL PAIN; ADULT; ANOREXIA; ANXIETY; ARTICLE; BACKACHE; BITTER TASTE; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DUODENUM ULCER; EPIGASTRIC PAIN; FEMALE; FEVER; FLATULENCE; GLOSSITIS; HEADACHE; HELICOBACTER INFECTION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALAISE; MALE; NAUSEA; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; SIDE EFFECT; THORAX PAIN; TREATMENT DURATION; VOMITING; XEROSTOMIA;

EID: 80053014973     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Egan BJ, Marzio L, O'Connor H, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter 2008;13(Suppl. 1):35-40.
2. Ernst PB, Crowe SE, Reyes VE. How does Helicobacter pylori cause mucosal damage? The in-amatory response. Gastroenterology 1997;113(suppl 6):S35-S42; discussion S50.
3. Peura DA. Helicobacter pylori and ulcerogenesis. Am J Med 1996;100:19S-25S; discussion S-6S.
4. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-1271.
5. Alexander GA, Brawley OW. Association of Helicobacter pylori infection with gastric cancer. Mil Med 2000;165:21-27.
6. European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report.Gut 1997;41:8-13.
7. Chey WD, Wong BCY. Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-1825.
8. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 2007;56:772-781.
9. Kaviani MJ, Malekzadeh R, Vahedi H, Sotoudeh M, Kamalian N, Amini M, et al. Various duration of a standard regimen (amoxicillin, metronidazole, colloidal bismuth subcitrate for 2 weeks or with additional ranitidine for 1 or 2 weeks on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial. Eur J GastroenterolHepatol 2001;13:915-919.
10. Salman-Roghani H, Massarrat S, Pahlewanzadeh MR, Dashti M. Effect of two doses of metronidazole and tetracycline in bismuth triple therapy on eradication of H.pylori and its resistant strains. Eur J GastroenterolHepatol 1999;11:709-712.
11. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J GastroenterolHepatol 1995;7(5):427-433.
12. Siavoshi F, Saniee P, Lati-Navid S, Massarrat S, Sheykholeslami A. Increase in Resistance Rates of H.pylori Isolates to Metronidazole and Tetracycline-Comparisonof Three 3-Year Studies Archives of Iranian Medicine, 2010;13(3).
13. Fakheri H, Malekzadeh R, Merat S, Khatibian M, Fazel A, Alizadeh BZ, et al. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment Pharmacol Ther 2001;15(3):411-416.
14. Fakheri H, Merat S, Hosseini V, Malekzadeh R. Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication. Aliment PharmacolTher 2004;19(1):89-93.
15. Saberi-Firoozi M, Massarrat S, Zare S, Fattahi M, Javan A, Etaati H, et al. Effect of triple therapy or amoxicillin plus omeprazole or amoxicillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: A prospective, randomized, controlled study. Am J Gastroenterol 1995;90:1419-1423.
16. Fischbach LA, Goodman KJ, Feldman M, Aragaki C. Sources of variation of Helicobacter pylori treatment success in adults worldwide: A meta-analysis. Int J Epidemiol 2002;31:128-139.
17. Vakil N. Are there geographical and regional differences in Helicobacter pylori eradication? Can J Gastroenterol 2003;17(Suppl. B):30B-32B.
18. Altamirano A, Bondani A. Adverse reactions to furazolidone and other drugs. A comparative review. Scand J Gastroenterol Suppl. 1989;169:70-80. [PubMed]
19. Kwon DH, Lee M, Kim JJ, Kim JG, El-Zaatari FA, Osato MS, et al. Urazolidone-and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance. Antimicrob Agents Chemother 2001;45:306-308.
20. Graham DY, Osato MS, Hoffman J, Opekun AR, Anderson SY, El-Zimaity HM. Furazolidone combination therapies for Helicobacter pylori infection in the United States. Aliment PharmacolTher 2000;14(2):211-215.
21. Daghaghzadeh H, Emami MH, Karimi S, Raeisi M. One-week versus two-week furazolidone-based quadruple therapy as the first-line treatment for Helicobacter pylori infection in Iran. J GastroenterolHepatol 2007;22(9):1399-1403.
22. Felga GE, Silva FM, Barbuti RC, Navarro-Rodriguez T, Zaterka S, Eisig JN. Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease. World J Gastroenterol 2008;14(40):6224-6227.
23. Cheng H, Hu FL. Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori. World J Gastroenterol 2009;15(7):860-864.
24. Sanches B, Coelho L, Moretzsohn L, Vieira G. Failure of Helicobacter pylori treatment after regimes containing clarithromycin: New practical therapeutic options.JrHelicobacter 2008;13(6):572-576.
25. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance.Gut 2010;59(8):1143-1153.Epub 2010 Jun 4
26. Lu H, Zhang DZ, Hu PJ, Li ZS, Lu XH, Fang XC, et al. Oneweek regimens containing ranitidine, bismuth citrate, furazolidone, and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: A multicenter, randomized, double-blind study. Aliment PharmacolTher 2001;15:1975-1979.
27. Liu WZ, Xiao SD, Hu PJ, Lu H, Cui Y, Tytgat GN. A new quadruple therapy for Helicobacter pylori using tripotassiumdicitratobismuthate, furazolidone, josamycin, and famotidine. Aliment PharmacolTher 2000;14:1519-1522.
28. Khatibian M, Ajvadi Y, Nasseri-Moghaddam S, Ebrahimi-Dariani N, Vahedi H, Zendehdel N, et al. Furazolidonebased, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease. Arch Iran Med 2007;10(2):161-167.
29. Hasan SR, Vahid V, Reza PM, Roham SR. Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori. Saudi J Gastroenterol 2010;16(1):14-18.
30. Graham DY, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy. Helicobacter. 2007; 12:275-278.